Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -19.48 |
peg ratio | 0.79 |
price to book ratio | 6.08 |
price to sales ratio | 13.13 |
enterprise value multiple | -23.04 |
price fair value | 6.08 |
profitability ratios | |
---|---|
gross profit margin | 60.75% |
operating profit margin | -53.92% |
pretax profit margin | -66.41% |
net profit margin | -66.92% |
return on assets | -20.06% |
return on equity | -29.69% |
return on capital employed | -19.15% |
liquidity ratio | |
---|---|
current ratio | 4.98 |
quick ratio | 4.90 |
cash ratio | 1.70 |
efficiency ratio | |
---|---|
days of inventory outstanding | 42.09 |
operating cycle | 115.05 |
days of payables outstanding | 48.10 |
cash conversion cycle | 66.96 |
receivables turnover | 5.00 |
payables turnover | 7.59 |
inventory turnover | 8.67 |
debt and solvency ratios | |
---|---|
debt ratio | 0.20 |
debt equity ratio | 0.31 |
long term debt to capitalization | 0.21 |
total debt to capitalization | 0.24 |
interest coverage | -12.59 |
cash flow to debt ratio | -0.45 |
cash flow ratios | |
---|---|
free cash flow per share | -1.14 |
cash per share | 6.66 |
operating cash flow per share | -0.85 |
free cash flow operating cash flow ratio | 1.35 |
cash flow coverage ratios | -0.45 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -2.88 |
Frequently Asked Questions
Legend Biotech Corporation (LEGN) published its most recent earnings results on 12-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Legend Biotech Corporation (NASDAQ:LEGN)'s trailing twelve months ROE is -29.69%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Legend Biotech Corporation (LEGN) currently has a ROA of -20.06%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
LEGN reported a profit margin of -66.92% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.98 in the most recent quarter. The quick ratio stood at 4.90, with a Debt/Eq ratio of 0.31.